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Summary
CD1a is expressed on Langerhans cells (LCs) and
dendritic cells (DCs), where it mediates T cell recogni-
tion of glycolipid and lipopeptide antigens that con-
tain either one or two alkyl chains. We demonstrate
here that CD1a-restricted T cells can discriminate the
peptide component of didehydroxymycobactin lipo-
peptides. Structure analysis of CD1a cocrystallized
with a synthetic mycobactin lipopeptide at 2.8 Å reso-
lution further reveals that the single alkyl chain is in-
serted deep within the A pocket of the groove,
whereas its two peptidic branches protrude along the
F pocket to the outer, -helical surface of CD1a for
recognition by the TCR. Remarkably, the cyclized ly-
sine branch of the peptide moiety lies in the shallow
F pocket in a conformation that closely mimics that
of the alkyl chain in the CD1a-sulfatide structure.
Thus, this structural study illustrates how a single
chain lipid can be presented by CD1 and that the pep-
tide moiety of the lipopeptide is recognized by the TCR.
Introduction
The human CD1 family of nonpolymorphic, glycosy-
lated antigen-presenting molecules consists of five pro-*Correspondence: wilson@scripps.eduteins, CD1a, CD1b, CD1c, CD1d, and CD1e, which are
expressed on professional antigen-presenting cells,
such as B cells, LCs, and DCs (Porcelli, 1995). The
functions of CD1 molecules are well studied in humans,
mice, and guinea pigs, and CD1 proteins have been
identified in all mammalian species studied to date
(Dascher and Brenner, 2003). The human family of CD1
proteins can be separated into two groups based on
their sequence similarity and immunological functions.
In humans, group 1 CD1 consists of CD1a, CD1b,
CD1c, and CD1e, whereas the only group 2 isoform is
CD1d (Calabi et al., 1989). Whereas group 1 CD1 pro-
teins are thought to participate in host defense by pre-
senting microbial lipid antigens to cytotoxic T cells,
group 2 proteins respond to endogenous antigens and
carry out immunoregulatory functions (Gumperz and
Brenner, 2001). Nevertheless, recent studies have
established a role for group 2 CD1 in host defense (Fi-
scher et al., 2004; Skold and Behar, 2003; Vincent et
al., 2003).
CD1a differs from the other group 1 CD1 molecules
in terms of cellular expression and intracellular localiza-
tion. Firstly, CD1a is the only CD1 protein to be consti-
tutively expressed at high levels on LCs, where Lang-
erin, an LC-expressed C type lectin participates in
glycolipid antigen capture and presentation to T cells
(Hunger et al., 2004). Secondly, unlike other CD1 iso-
forms, which have endosomal targeting sequences in
their cytoplasmic tails and recycle to LAMP1+ late en-
dosomes, the short cytoplasmic tail of CD1a lacks such
motifs, so that this isoform localizes predominantly at
the cell surface with only low levels in recycling endo-
somes.
CD1 exhibits a similar fold and architecture as major
histocompatibility complex (MHC) class I molecules,
but its binding groove has evolved into a narrow and
deep hydrophobic cleft, more suited to binding lipids
and glycolipids (Gadola et al., 2002; Zajonc et al., 2003;
Zeng et al., 1997). This binding groove is formed by the
two interconnecting pockets, A# and F#, in mouse CD1d
and human CD1a. The A# pocket is completely buried
deep inside the protein and connected to the solvent
via the F# pocket, which extends from the A#-F# junc-
tion to the protein surface. In addition to the A# and F#
pockets, CD1b bears a T# tunnel that runs below the F#
pocket and a C# portal, which is located underneath
the α2 helix and connects the interior groove with the
outer surface of CD1. These additional pockets are
necessary for the accommodation of larger lipids, such
as mycolic acids, which contain up to 80 carbon atoms.
The variety of different classes of lipid antigens that
has been identified so far includes self-antigens, such
as the common phosphoglycerolipids (De Silva et al.,
2002; Gumperz et al., 2000; Joyce et al., 1998) and sphin-
golipids (Kawano et al., 1997; Shamshiev et al., 1999,
2002; Wu et al., 2003), and foreign lipids, such as lipoar-
abinomannan (Sieling et al., 1995), phosphatidylinositol
mannoside (Fischer et al., 2004), mycolic acids (Beck-
man et al., 1994), glucose monomycolates (Moody et al.,
1997), diacylated sulfoglycolipids (Gilleron et al., 2004),
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210and mannosyl phosphodolichols (Moody et al., 2000) (
bfrom Mycobacterium tuberculosis and related patho-
genic microbes. CD1a can present certain exogenously m
dacquired mycobacterial lipid antigens to specific αβ T
cell receptors (TCRs) for host cell defense (Rosat et l
fal., 1999).
However, the natural diversity and biological rele- k
fvance of these CD1 antigens has remained elusive until
recently. The identification of mycobacterial lipopep- t
wtides as a new class of CD1-restricted antigens (Moody
et al., 2004) provided the first example of a bacterial f
antigen specific to CD1a. These lipopeptides are called
didehydroxymycobactin (DDMs) and belong to the s
aN-aryl-capped mycobactin subfamily of the sidero-
phores, which are iron-chelating molecules (Snow and a
hWhite, 1969). Upon infection, mycobacteria scavenge
iron from the host cell by expressing both cell-associ- s
tated and secreted siderophores, which bind iron with
a remarkable affinity and transport it to the cell wall l
e(Wooldridge and Williams, 1993). The synthesis of N-aryl-
capped mycobactins is carried out by a multimodular (
aenzyme complex, which consists of nonribosomal pep-
tide synthetases (NRPSs) and polyketide synthases o
m(PKSs) (Crosa and Walsh, 2002; Quadri, 2000), whereby
the peptide chain is first elongated and then acylated s
Dand hydroxylated to form the final product. The synthe-
sis of mycobactins is essential for mycobacterial growth p
dinside macrophages (De Voss et al., 2000). These natu-
ral products represent the first known lipopeptide anti- e
lgens presented by CD1 proteins and suggest that CD1-
restricted TCRs, like MHC-restricted TCRs, can also 8
ldiscriminate polypeptide sequences. Interestingly, al-
though the CD1a binding groove is highly hydrophobic u
0and relatively rigid, the repertoire of bound antigens is
quite chemically diverse. The CD1a sulfatide self-anti- i
mgen, a common sphingolipid, is composed of two alkyl
chains, a sphingosine backbone and a fatty acid, and
a sulfated galactose headgroup. On the contrary, DDM S
lipopeptide foreign antigens are composed of a single o
alkyl chain and a more complex headgroup formed by T
amino acids and organic acids. p
Here, we report the crystal structure of CD1a in com- h
plex with a synthetic mycobactin lipopeptide JH-02215, p
which demonstrates how a single alkyl chain is an- n
chored in the binding groove and how the peptidic por- p
tion protrudes from the groove for T cell recognition. a
Thus, lipopeptide presentation to T cells involves a mo- c
lecular mode of recognition that has features of both D
CD1 and MHC molecules because it involves TCR re- 8
cognition of the peptide, like MHC molecules, and lipid c
anchoring in the binding groove, as in CD1. a
i
wResults
a
pT Cell Activation by CD1a with Bound Lipopeptides
Is Specific for the Peptide Moiety v
oDDM lipopeptides are assembled from five organic
acids, salicylic acid, methylserine, lysine, hydroxybuty- u
rate, and lysine that form the peptidic headgroup. The
 amino group of the central lysine is then acylated with i
aa C20, monounsaturated fatty acid, and the terminal ly-
sine is cyclized as a result of intramolecular attack t
tof its  amino group on its own terminal carboxylateFigure 1B). Thus, the peptide moiety consists of two
ranches, the N-aryl branch composed of salicyl-
ethylserine and the lysine branch composed of hy-
roxybutyryl-lysine, which radiate from the central acy-
ated lysine (Figure 1B). Although the structural basis
or recognition of these molecules by CD1a was un-
nown, we proposed from modeling studies that the
atty acyl unit of DDMs would be inserted deeply into
he A# pocket of the hydrophobic binding groove,
hich would leave the polypeptide exposed on the sur-
ace of CD1a (Moody et al., 2004).
To determine whether the CD1a-mediated T cell re-
ponse is, indeed, specific for these organic and amino
cids that form the polypeptide, DDM homologs with
ltered peptide structures were isolated. First, we used
igh pressure liquid chromatography (HPLC) to isolate
pontaneous hydrolysis products of DDM cleaved at
he internal ester group; the resulting product lacks the
ysine branch, and the [M + H]+ was detected by
lectrospray ionization mass spectrometry at m/z 642
DDM-642). In addition, DDM was treated with trifluoro-
cetic acid (TFA) to modify the aryl branch through
pening of the oxazoline ring formed from the salicyl-
ethylserine linkage. Collision-induced dissociation mass
pectrometric analysis (CID-MS) showed that intact
DM, [M + H]+ m/z 838 (DDM-838), was converted to a
roduct whose [M + H]+ appears at m/z 856 (DDM-856)
ue to the addition of a single water molecule at the
xpected position. The CD1a-restricted reporter T cell
ine CD8-2 showed little or no response to both DDM-
56 and DDM-642, providing evidence that the aryl and
ysine branches both play a role in T cell activation (Fig-
re 1A). Furthermore, the synthetic lipopeptide JH-
2215 failed to stimulate the same T cell line, suggest-
ng that the moieties added to the C-terminal lysine
ask the antigenic T cell epitope (Figure 1B, right).
tructure Determination
f the CD1a-Lipopeptide Complex
o directly study the molecular mechanism of this lipo-
eptide recognition by CD1, we sought to crystallize
uman CD1a with lipopeptides. Because DDMs from
athogenic mycobacteria can be produced only in na-
ogram to microgram quantities, synthetic DDM-like li-
opeptide (JH-02215) was selected for crystallization,
s it could be produced in adequate quantities and re-
apitulated most of the chemical structural features of
DM (Figure 1B). Compared to mycobacterial DDM-
38 (C20), JH-02215 has a shorter (C16) saturated alkyl
hain, lacks the α-methyl group on its serine moiety,
nd carries a hydroxyl group on the central lysine, as
n mycobactin. In addition, JH-02215 was synthesized
ith its lysine attached to a silicon atom carrying two
dditional phenyl and one tertiary butyl group that im-
roved chemical yield and was predicted not to be in-
olved in CD1a binding. JH-02215 mimics all of the
ther chemical features of DDM (shown in black in Fig-
re 1B) and binds to human CD1a.
Soluble CD1a protein was produced in the Drosoph-
la melanogaster expression system (DES) and purified
s previously described (Zajonc et al., 2003). After par-
ial demannosylation of CD1a, the hexahistidine affinity
ag was removed by carboxypeptidase A digestion. The
Structure of the CD1a-Lipopeptide Complex
211Figure 1. T Cell Stimulation by Lipopeptide Antigens
(A) The CD1a-restricted reporter T cell line CD8-2 was tested for its ability to release IL-2 in response to monocyte-derived dendritic cells to
purified DDMs with a unsaturated C20 acyl chain (DDM-838) or to DDM-like lipopeptides (DDM-856, DDM-642, and synthetic JH-02215). Only
DDM-838 supported significant release of IL-2. The data are shown as the mean ± SD and are representative of two or more experiments.
(B) Structures of studied lipopeptides with chemical differences are shown in red.synthetic lipopeptide JH-02215 was loaded onto CD1a
after forming mixed micelles with Tween 20 detergent.
By using the sitting drop vapor diffusion method, we
obtained high-quality diffracting crystals in a crystalli-
zation condition similar to that reported for the CD1a-
sulfatide complex (Zajonc et al., 2003). As the crystal
unit cell dimensions were almost identical to the CD1a-
sulfatide crystals, we determined the CD1a-lipopeptide
structure by molecular replacement using the CD1a-
sulfatide structure (1ONQ). The complex structure was
refined to a resolution of 2.8 Å (Table 1 and Figure 2A)
and final Rcryst and Rfree values of 21.7% and 27.7%,
respectively. The asymmetric unit of the crystal con-
tained two CD1-lipopeptide complexes (A and B),
which were very similar due to tight noncrystallo-
graphic symmetry (NCS) restraints. However, the ap-
plied NCS averaging of the electron density did not im-
prove the electron density for the ligand, which had
weaker and overall less well-defined electron density,consistent with higher B values for the protein itself.
Therefore, we describe here the structural features of
the CD1a-ligand complex A, except where otherwise
stated.
Interactions between the Lipopeptide and CD1a
As in the CD1a-sulfatide structure, the CD1a-β2M het-
erodimer is composed of the three CD1a heavy chain
domains, α1, α2, and α3, noncovalently associated with
β2M (Zajonc et al., 2003). The α1 and α2 helices form a
narrow and deep antigen binding groove on top of a
six-stranded β sheet platform. The antigen binding
groove consists of the deeply buried A# pocket and the
shallow F# pocket, which connects the A# pocket with
the outer surface of CD1a. When compared to the
CD1a-sulfatide structure, no major conformational dif-
ferences are observed in the global conformation of
CD1a when bound to lipopeptide; key residues that
form the binding groove are also not substantially al-
Immunity
212aTable 1. Data Collection and Refinement Statistics for the CD1a-
aLipopeptide Complex
a
Data Collection d
Resolution range (Å)a 50.0–2.8 (2.9–2.8) g
Completeness (%)a 94.4 (85.5)
Number of unique reflections 24,273 t
Redundancy 3.0
oRsyma,b (%) 9.8 (44.4)
aI/σa 14.6 (2.2)
eRefinement Statistics
p
Number of reflections (F > 0) 22,766 u
Maximum resolution (Å) 2.8
mRcrystc (%) 21.7
lRfreed (%) 27.7
l
Number of Atoms
t
Protein 6,031 t
Lipopeptide ligand 101
tN-linked carbohydrate 62
eWater 19
i
Ramachandran Statistics (%)
v
Most favored 90.3 m
Additional allowed 9.3 a
Generously allowed 0.2
FDisallowed 0.3
p
Rmsd from Ideal Geometry
e
Bond length (Å) 0.013 s
Bond angles (°) 1.48 s
Average B Values (Å2)e t
fProtein 54.5
Lipid ligand 74.9 s
a Numbers in parentheses refer to the highest resolution shell.
ab Rsym = (ShSirIi(h) − <I(h)>Ir(ShSIIi(h)) × 100, where <I(h)> is the average
intensity of i symmetry-related observations with reflections with l
Bragg index h. a
c Rcryst = (ShklrFo − Fcr/ShklrFor) × 100, where Fo and Fc are the c
observed and calculated structure factors, respectively, for all data.
bd Rfree was calculated as for Rcryst but on 5% of data excluded
Tbefore refinement.
Ne B values were calculated with the CCP4 program TLSANL (CCP4,
1994; Howlin et al., 1993). o
h
D
Otered despite the differences in the number of alkyl
bchains (one versus two) and the chemical nature of the
whydrophilic head groups of these two antigens. The
hroot mean square deviation (rmsd) of the Cα atoms of
the α1-α2 domain (A1-180) between the two structures
is only 0.42 Å. Thus, the CD1a binding groove appears C
Lto be a rather rigid cavity in which two ligands of quite
different chemical composition maneuver to optimally I
pfit the available pockets.
As the central lysine residue of the peptidic head- s
sgroup is N amide-linked through its  amino group to
the C16 fatty acyl chain, the total length of the alkyl c
bchain then extends to 21 carbons. The lipopeptide li-
gand is bound mainly through van der Waals contacts, t
cwith the C21 alkyl chain inserted so that its terminal
methyl unit is located at the end of the A# pocket (Fig- a
sure 2B). Similar to the sulfatide, most of the dihedral
angles of the alkyl chain of the lipopeptide in both t
amolecules (A and B) are in preferred conformations,
close to their minimum energy state. A few dihedral an- t
Agles do not adopt these conformations as they are, to-
gether with the gauche conformers, necessary for thelkyl chain to adopt both the U-shape conformation
round the central pole of the A# pocket (Phe70, Val12)
nd the curved entry into the F# pocket. Of the 36 dihe-
ral angles, 21 are in trans (lowest energy) and 6 in
auche+ or gauche− (6 kJ/mol higher energy).
The connecting lysine is situated at the A#-F# intersec-
ion and anchors the branched headgroup at the bottom
f the F# pocket (Figure 2B). Both peptidic branches
re folded up so as to form a U shape, whereas the
nds of the branches, representing the tips of the U,
rotrude to the T cell recognition surface of CD1a (Fig-
re 3B). The N-aryl branch (Figure 2C) is located on the
edial side of the F# pocket close to Arg73 and stabi-
ized by hydrogen bonding. The lysine branch is on the
ateral side of the F# pocket, close to Tyr84. Compared
o bacterial DDMs, the synthetic lipopeptide has addi-
ional phenyl groups and the ter-butyl group attached
o the distal lysine, which are not ordered in the
lectron density maps and were, therefore, not included
n the final structure (Figures 2C, 3A, and 3B). The B
alues for the ligand and the protein residues are al-
ost identical in the A# pocket and gradually increase
s the ligand protrudes from the A#-F# junction into the
# pocket and up to the T cell recognition surface. This
henomenon of increasing B values and partial loss of
lectron density for the ligand at the T cell recognition
urface of CD1a was also observed in CD1a-sulfatide
tructure (Zajonc et al., 2003) and is most likely due to
he paucity of contacts for the headgroup, especially
or those moieties protruding farthest from the CD1a
urface.
Hydrogen bonding occurs mainly between the N-aryl
nd the lysine branches of the peptidic moiety of the
igand with Arg73 and Ser77 of the A#-F# intersection
nd the F# pocket, respectively (Figure 4). Arg73, lo-
ated on the α1 helix, plays a crucial role in hydrogen
onding, as it simultaneously interacts with Glu154 and
hr158 of the α2 helix and with the oxazoline ring of the
-aryl branch of the lipopeptide. Consistent with a role
f Arg73 in stabilizing the ligand for T cell recognition,
ydrolysis of the oxazoline ring in DDM-838 to form
DM-856 results in loss of T cell recognition (Figure 1).
n the lateral side of the F# pocket opening, the lysine
ranch is stabilized by the backbone oxygen of Ser77,
hich forms the only hydrogen bond between the α1
elix and the peptide bond in the lysine branch.
omparison of Sulfatide versus Synthetic
ipopeptide
n addition to the basic differences in the chemical com-
osition of their hydrophilic head groups, CD1a bound
ulfatides and lipopeptides differ in the number (two ver-
us one) and overall length (C36 versus C21) of their alkyl
hains. A comparison of their conformations when
ound in the CD1a groove provides some insight into
he mechanisms by which CD1a can present chemi-
ally diverse ligands (Figure 5A). The distal ends of the
lkyl chain of the lipopeptide ligand and the sphingo-
ine base of the sulfatide ligand are both inserted into
he A# pocket such that they occupy a similar location
nd conformation. However, the proximal ends of these
wo alkyl chains take very different paths across the
#-F# junction. In the sulfatide structure, the sphingo-sine chain bends laterally and upward to make a sharp
Structure of the CD1a-Lipopeptide Complex
213Figure 2. Overview of the CD1a-Lipopeptide
Structure
(A) Cartoon representation (front view) of the
CD1a (α1–α3 domains)-β2M heterodimer
(light gray) with bound lipopeptide JH-02215
(yellow). N-linked glycosylation sites and
carbohydrates are in green. Atom colors for
all structural representations: yellow, carbon;
red, oxygen; blue, nitrogen; and pink, silicon.
(B) Top view looking into the CD1a binding
groove. The individual pockets of the binding
groove are color coded to highlight the dif-
ferent pockets (pink, A#; green, F#; and blue
A#-F# junction). N20, N43, N57, and N128 re-
present the four N-linked glycosylation sites.
Only for N57 could two sugars be modeled,
with presumed disorder for the sugars at the
other glycosylation sites.
(C) Chemical structure of the synthetic lipo-
peptide JH-02215. The chemical elements of
the ligand are colored to match the corre-
sponding regions of the binding groove (B)
in which the different moieties of the ligand
(alkyl chain, acylated lysine, and peptide) are
bound. Yellow-colored chemical groups are not present in the final structure due to a lack of any convincing electron density and, hence, are
likely disordered. The terms N-aryl branch and lysine branch are used throughout the article to describe the two different segments of the
peptidic headgroup of the ligand.of the sulfatide ligand. Surprisingly, the lysine branch In particular, the terminal portions of the alkyl chain are
Figure 3. Conformation of the Lipopeptide JH-02215 in the CD1a Binding Groove
After omitting the lipopeptide ligand coordinates, a shake-omit FO − FC map was calculated and contoured at 1.8 σ as a green mesh around
the ligand (yellow). Several important contact residues of the A# and F# pocket (A# and F#, respectively) are depicted and labeled.
(A) View looking down into the binding groove (TCR view).
(B) Side view, after removing the α2 helix for clarity.S-shaped curve, whereas the lysine moiety of the lipo-
peptide takes a relatively straight path across the A#-
F# junction (Figure 5A, right). The extra curve in the sul-
fatide ligand serves to position the sulfogalactosyl
headgroup more laterally and superiorly in the F#
pocket, so that this hydrophilic moiety is located near
the TCR contact surface. Also, the S-shaped kink bur-
ies a larger number of methylene units of the longer
sulfatide chain within the groove, where the ligand
makes extensive van der Waals contacts with the interior
of the groove. Comparison of structures in the F# pocket
shows that the N-aryl branch of the lipopeptide is lo-
cated in a position similar to the sulfogalactosyl moietyThe N-aryl-branch is less well ordered than the aliphatic backbone or th
groups extending from the end of the lysine branch of the synthetic DDMmimics the path and conformation of the correspond-
ing fatty acyl chain of the sulfatide (Figure 5A, left).
Many of the residues that are involved in hydrogen
bonding with the galactose headgroup of the sulfatide
to CD1a also function in stabilizing the N-aryl and cy-
clized lysine moieties of the lipopeptide.
Comparison of Natural (DDM-838) versus Synthetic
(JH-02215) Lipopeptide
Overall, good agreement is found between the crystal
structure of CD1a-JH-02215 and the previously pro-
posed, energy-minimized model of CD1a bound to my-
cobacterial DDM-838 (Figure 5B) (Moody et al., 2004).e lysine-branch. No electron density for the ter-butyl and phenyl
(highlighted in yellow in Figure 2C) is visible.
Immunity
214Figure 4. Stereoview of the Hydrogen-Bond
Network Stabilizing the Peptidic Headgroup
of the Ligand
The lipopeptide ligand bound in the CD1a
binding groove is shown in a side view,
where the first half of the α2 helix (residues
137–152) is omitted for clarity. Hydrogen
bonds between the protein residues were
assessed with the program HBPLUS (Mc-
Donald and Thornton, 1994) and drawn as a
blue dotted line. Hydrogen bonds between
the protein and the lipopeptide ligand were
assessed with the program CONTACT as
part of the CCP4 suite (CCP4, 1994) based
on the distance and termed potential, as
they do not strictly meet the angle requirements. Arg73 (R73) serves as the major hydrogen donor as it interacts with Glu154 (E154) and
Thr158 (T158) of the α2 helix and partially stabilizes the N-aryl branch of the ligand.located in the A# pocket, and the relative orientation of t
sthe N-aryl and lysine branches on the medial and lateral
walls of the F# pocket are essentially the same in both h
sstructures. The main difference between the structures
relates to the depth of tethering of the U-shaped lipo- t
peptide moiety within the F# pocket. This difference is
best explained by the differences in length of the alkyl M
Tchain found in JH-02215 (C16) and DDM-838 (C20). The
shorter fatty acid chain in the CD1a-JH-02215 structure A
(lipid takes a direct path across the A#-F# junction,
whereas the DDM-838 model depicts the lipid in an I
sS-shaped conformation, similar to the known path of tanding of the mechanism of CD1-ligand recognition
Figure 5. Comparative Binding Analysis of Different CD1a Ligands
Electrostatic surfaces of the CD1a binding groove are shown as transparent binding pockets with bound ligands. The electrostatic surface
potential was calculated in GRASP (Nicholls et al., 1991) (−15 to +15 kT/e) and demonstrates the highly hydrophobic nature of the binding
groove. Red is electronegative and blue is electropositive. Superimposition of the different ligands is shown in a side view (left) and in a top
view looking into the groove (right). A# and F# pockets are labeled as such. The ligand only protrudes to the surface in the F# pocket but is
completely buried in the A# pocket and A#-F# junction.
(A) Superimposition of the sulfatide (salmon) with JH-02215 (yellow) using
(B) Superimposition of the modeled DDM-838 structure (pink) with the cryhe longer alkyl chain in the sulfatide. Furthermore, the
horter alkyl chain of JH-02215 tethers the peptidic
eadgroup more deeply within the F# pocket, which re-
ults in more limited exposure of the peptide termini at
he TCR contact surface (Figure 5B, left).
odel of the CD1a-Lipopeptide-TCR
rimolecular Complex
model of the DDM-838 lipopeptide-specific αβ TCR
CD8-2) was constructed, by analogy to MHC class
-TCR complex structures, in order to facilitate under-their crystal structure coordinates 1ONQ and 1XZ0.
stal structure JH-02215 (yellow).
Structure of the CD1a-Lipopeptide Complex
215Figure 6. TCR-CD1a-Lipopeptide Complex Model
A model of a TCR CD1a-lipopeptide trimolecular complex was computed as described in the Experimental Procedures. The top panel
shows a model of the CD1a-dideoxymycobactin specific αβ TCR CD8-2, whereas the bottom panel depicts the CD1a-JH-02215 lipopeptide
crystal structure.
(A and B) Electrostatic surface representation of CD1a and TCR CD8-2 is shown. Surfaces and electrostatic potentials were calculated in
GRASP (Nicholls et al., 1991). Red is electronegative and blue is electropositive (−15 to +15 kT/e). (A) View of the contact surfaces that are
involved in TCR-CD1a complex formation. Top, view down onto the TCR CDR loops of the variable α and β domain (Vα and Vβ, respectively).
Bottom, view looking down into the CD1a binding groove, with bound ligand in yellow. Note how little lipopeptide antigen is visible. (B) Front
view of the modeled TCR-CD1a complex, with the TCR and CD1 slightly pulled apart.
(C) Front view of the TCR-CD1a complex interaction similar to (B). The Cα atom trace is shown in light gray (CD1a-β2M and TCR α chain) and
blue gray (TCR β chain). The complementarity determining regions (CDRs) are colored as follows: CDR1α, brown; CDR2α, green; CDR3α,
light blue; CDR1β, orange; CDR2β, light green; and CDR3β, dark blue. The carbon atoms of the lipopeptide ligand JH-02215 are in yellow,
oxygens are red, and nitrogens are blue. Note that the α chain contacts primarily CD1a residues, as the lipid below in the A# pocket is
completely buried. Vβ contacts both CD1a and the peptide portion of the ligand.by CD1-restricted T cells. Compared to MHC class I
and class II, in which the peptide ligands are exposed
at the MHC surface along the α1-α2 domain, most of
the CD1 ligands are occluded by the CD1 protein itself
(Batuwangala et al., 2004; Gadola et al., 2002; Zajonc
et al., 2003). The antigenic carbohydrate or peptidic
epitopes of the glycolipids and lipopeptides, respec-
tively, are the only components that protrude to any ex-
tent at the CD1 surface (Figures 6A and 6C), although
one of the alkyl chains in the sulfatide bound to CD1a
also reaches the surface. In the case of CD1a-restricted
T cells, most of the complementarity determining re-
gions (CDRs) only encounter the nonpolymorphic CD1
protein surface, rather than the ligand, especially for Vα
recognition of the CD1 surface above the A# pocket.
The CDRs of the α chain (CDRα) are likely to interact
primarily with the surface of CD1 on the N- and C-ter-
minal side of the α1 and α2 helices, respectively, where
the bound ligand is not exposed. The ligand is only
exposed in the F# pocket towards the C-terminal end
of the α1 helix (Figures 6A and 6C), where the CDRs of
the β chain (CDRβ) are well positioned to interact with
the peptidic headgroup of the lipopeptide (Figure 6C).
It is possible that CDR3α, if of appropriate length and
conformation, could extend over to this side, as seen in
the TCR (A6 and B7) interactions with HLA-A2 peptidecomplexes (Ding et al., 1998; Garboczi et al., 1996). Al-
though specific interactions between individual resi-
dues of trimolecular complex cannot be quantitated at
present, the charged residues that surround the entry
to the binding groove in CD1a are likely to be located
in close proximity to the CDR loops of the β chain, in
particular to CDR3β but also to CDR3α, which would
also confer specificity for this particular CD1 isotype.
The possibility of other CD1-TCR docking orientations
cannot be discounted, but it seems reasonable to as-
sume that the CDRs of the TCR and the antigenic epi-
tope of the CD1 bound ligand must come into close
proximity for recognition events, similar to TCR docking
onto MHC molecules. Slightly different docking orienta-
tions of the TCR on MHC class I and class II molecules
have been observed (Rudolph and Wilson, 2002) that
lead to a slightly different disposition of the CDRs with
respect to the presented antigens, but such subtle
changes cannot be predicted yet for TCR-CD1 dock-
ing models.
Discussion
MHC class I and II proteins present peptidic antigens for
which many of the sequence-specific differences in pep-
tide binding are accounted for by allelic polymorphisms
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structures to accommodate different ligands. CD1 pro- f
teins are nonpolymorphic, yet they present a diversity A
of antigenic structures including mycolates, diacylglyc- t
erols, isoprenoid lipids, sphingolipids, lipopeptides, and t
small hydrophobic molecules (Beckman et al., 1994; De t
Silva et al., 2002; Gumperz et al., 2000; Joyce et al., 2
1998; Kawano et al., 1997; Moody et al., 1997, 2000,
2004; Shamshiev et al., 1999, 2002; Sieling et al., 1995; m
Wu et al., 2003). Even the same CD1 isoform can pre- b
sent antigens of markedly different structures, as il- r
lustrated by CD1a, which presents self-sulfoglycolipids t
with two alkyl chains and foreign lipopeptides with one T
alkyl chain to T cells (Moody et al., 2004; Zajonc et al., t
2003). Thus, an understanding of how antigen binding v
grooves of nearly invariant structure can specifically d
bind such chemically diverse antigens has emerged as a
a central problem in understanding the structural basis t
of antigen presentation by CD1. Here, the crystal struc- f
ture of CD1a bound to a synthetic lipopeptide antigen t
has provided further insights into the molecular mecha- C
nism of antigen binding by showing how alkyl chains of a
a discrete length are captured via a conserved mecha- r
nism in the A# pocket, whereas the F# pocket binds the b
diverse chemical elements of each ligand in different
w
and flexible ways.
s
Initially, it was not easy to comprehend how CD1a
Wproteins could present both sulfatides that have two
falkyl chains and lipopeptides with a single alkyl chain.
gThe CD1a-JH-02215 structure provides a clear and sur-
bprising answer to this question by illustrating that the
plateral wall of the F# pocket can accommodate either
mthe N-aryl branch of a lipopeptide or the acyl chain of
tsulfatides, where these diverse moieties follow nearly
the same path (Figure 5A). Furthermore, the longer
chain lengths of the alkyl chains in the sulfatide (C36) E
are accommodated in part by the prolonged S-shaped
diversion through the broader A#-F# portal region, in P
Tcontrast to the direct path taken by the shorter (C21),
tsingle chain JH-02115. Moreover, the anchoring of each
alipid terminus at the distal end of the A# pocket leads
bto a more subtle mechanism in which the S-shaped
Cconformation at the A#-F# junction compensates for
1
some variation in the alkyl chain length so as to facili- U
tate correct positioning of the ligand headgroups for r
TCR contact within the F# pocket. Antigens that vary s
from this restricted optimal length by more than the A
Hsmall amount of tolerance provided by the S-shaped
µdiversion would make inadequate or inappropriate con-
ftacts with the hydrophobic binding groove, resulting in
dweaker and less efficient binding. Studies on CD1a pre-
d
sentation of DDM-lipopeptides have shown that DDMs p
that vary slightly in alkyl chain length and saturation o
state can all be recognized, but the presence of a single a
unsaturation at the C2–3 position or extension of the u
jacyl chain length from C18 to C20 surprisingly increases
Hantigenic potency (Moody et al., 2004). The molecular
pmechanism by which the C2–3 cis unsaturation in-
acreases DDM potency by 40-fold has not been eluci-
tdated, but its location at the A#-F# junction suggests
t
that it could favor an S-shaped configuration. This pre- (
cise lipid length discrimination of DDM homologs has o
not been described for α-galactosyl ceramides pre- m
msented by mCD1d; furthermore, hCD1b can presentlucose monoycolates that vary substantially in length
rom C12–80. These two isoforms lack the blunt-ended
# pocket seen in CD1a and also have larger F# pockets
hat connect back to the A# pocket (CD1d) or the T#
unnel (CD1b), which allows accommodation of lipid
ails of varied and longer length (Batuwangala et al.,
004; Gadola et al., 2002; Zeng et al., 1997).
These studies also provide evidence that the TCR-
ediated discrimination of DDM antigens is focused on
oth the N-aryl and lysine branches of the peptide and
eveals that the termini of these branches are adjacent
o the surface of CD1a that is predicted to serve as the
CR contact region (Figure 6). The hydrolysis reaction
hat renders DDM-856 unrecognizable to T cells in-
olves the methylserine component that forms a hy-
rogen bond with Arg73 on the α helix so that this alter-
tion likely affects the positioning of the peptide within
he F# pocket (Figures 1 and 5). More generally, the
unctional data show that the peptidic headgroup con-
rols the T cell response and is consistent with the
D1a-JH-02215 structure where this moiety is exposed
t the T cell recognition surface. Thus, a CD1a-
estricted TCR, as for MHC-restricted TCRs, appears to
e able to scan and respond in a sequence-specific
ay to peptide ligands. DDM lipopeptides are nonribo-
omally encoded and invariant in sequence (Crosa and
alsh, 2002). However, the ability of the F# pocket to
lexibly accommodate ligands of varied structure sug-
ests the possibility that other lipopeptides, encoded
y mammalian DNA or viral RNA and acylated during
osttranslation processing, might constitute an even
ore diverse array of antigens that can be presented
o human αβ T cells.
xperimental Procedures
rotein Expression, Purification, and Crystallization
he extracellular domain of CD1a was expressed, purified, and par-
ially deglycosylated as previously reported (Zajonc et al., 2003). In
ddition, the C-terminal hexahistidine tag was truncated by car-
oxypeptidase A digestion. In brief, 8 mg of the heterodimeric
D1a-β2M protein was incubated for 18 hr at room temperature in
00 mM Tris-HCl buffer at (pH 7.7) with carboxypeptidase A (1
/mg CD1 protein; Sigma, C9268). An average loss of four histidine
esidues was observed by mass spectrometry analysis (data not
hown). The CD1a-β2M protein was purified from carboxypeptidase
by anion exchange chromatography on MonoQ in 10 mM Tris-
Cl (pH 8.5). Lipopeptide loading was performed as follows: 200
g of the lipopeptide antigen was dissolved in 40 µl chloro-
orm:methanol (1:1) and mixed vigorously with 1 ml 1% Tween 20
etergent solution. The mixed lipopeptide-Tween 20 micelles were
iluted with 4 ml CD1a-β2M protein in 100 mM potassium phos-
hate buffer at (pH 6.0) to a final molar ratio of lipopeptide to CD1a
f 3:1 and incubated for 18 hr at room temperature under gentle
gitation. The CD1a-lipopeptide mix was concentrated to 2 ml by
sing a 4 ml ultrafiltration device (Amicon, 30 kDa MWCO) and sub-
ected to size exclusion chromatography (SEC) on Superdex S200
R16/60. Fractions containing monomeric CD1a-β2M protein were
ooled and concentrated to 8.5 mg/ml in 10 mM HEPES at pH 7.5
nd 30 mM NaCl. A second batch of protein was prepared by using
his protocol and concentrated to 15 mg/ml. Nanodrop crystalliza-
ion trials (100 nl drops) were performed by a crystallization robot
Syrrx), and initial crystallization conditions were reproduced and
ptimized manually by using the sitting drop vapor diffusion
ethod. The best crystals were obtained at room temperature by
ixing 1 µl protein (15 mg/ml) with 1 µl precipitant solution (24%
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217polyethylene glycol monomethylether [MPEG] 2000 and 0.1 M Tris-
HCl [pH 8.0]).
Structure Determination
Crystals were flash cooled at a temperature of 100 K in mother
liquor containing 20% glycerol. Diffraction data from a single crys-
tal were collected at Beamline 8.3.1 of the Advanced Light Source,
Berkeley and processed to 2.8 Å with the Denzo-Scalepack suite
(Otwinowski and Minor, 1997) in spacegroup P21 (unit cell dimen-
sions: a = 55.96 Å; b = 43.23 Å; c = 209.94 Å; β = 91.04°). As the
unit cell dimensions are almost identical to the CD1a-sulfatide
crystal, with two CD1a-β2M heterodimers per asymmetric unit
(molecules A and B), molecular replacement was straightforward
using the CD1a-sulfatide structure (1ONQ) as the initial model. Sub-
sequent rigid-body refinement in CNS version 1.1 (Brünger et al.,
1998) to a resolution of 3.5 Å resulted in an Rcryst of 36.8% (Rfree of
37.2%). The initial refinement included several rounds of simulated
annealing starting at 2000 K, conjugate gradient minimization, and
restrained temperature-factor refinement against the maximum
likelihood target (Pannu and Read, 1996). Tight NCS restraints were
maintained between the two molecules in the asymmetric unit
throughout the refinement. Furthermore, lowering the NCS weights
at the final stages of the refinement resulted in an increase in Rfree
and was, therefore, not used. The refinement progress was judged
by monitoring the Rfree for crossvalidation (Brünger, 1992). The
model was rebuilt into σA-weighted 2Fo − Fc and Fo − Fc difference
electron density maps by using the program O (Jones et al., 1991).
At a later stage of refinement, N-linked carbohydrates were built at
two out of the eight total Asn-X-Thr/Ser motifs in molecules A and
B. Water molecules were assigned during the refinement in CNS
for >3 σ peaks in an Fo − Fc map and retained if they satisfied
hydrogen bonding criteria and returned 2Fo − Fc density >1 σ after
refinement. Starting coordinates for the lipopeptide ligand were ob-
tained with the molecular modelling system INSIGHT II (Accelrys,
Inc.) and then energy minimized for 100 cycles with Discover. The
lipopeptide library for REFMAC (Murshudov et al., 1997) was cre-
ated by using the CCP4 program suite 5 (CCP4, 1994; Potterton et
al., 2003). Final refinement steps were performed by using the TLS
procedure in REFMAC (Winn et al., 2001) with a total of four aniso-
tropic domains (domains 1 and 3, α1-α2 domain of CD1a including
carbohydrates and lipopeptide ligand of molecules A and B; do-
mains 2 and 4, α3 domain and β2M of molecules A and B) and
resulted in improved electron density maps for the lipopeptide li-
gand and a further drop in Rfree. To reduce phase bias, a “shake-
omit map” was calculated as a difference map by using CCP4. Af-
ter omission of the lipopeptide ligand, the remaining coordinates
were perturbated in Moleman2 (Kleywegt, 1997) to a final rmsd of
0.2 Å. In addition, random shifts of up to 20 Å2 and up to 0.05 were
applied to the B values and the occupancies, respectively. The
CD1a-lipopeptide structure has a final Rcryst = 21.7% and Rfree =
27.7%. The quality of the model was assessed with the program
Molprobity (Lovell et al., 2003).
TCR Modeling
A homology model of the CD1a-dideoxymycobactin restricted αβ
T Cell clone CD8-2 was calculated with the Swiss Model Server
(Schwede et al., 2003). The coordinates of the model and the CD1a-
lipopeptide structure were superimposed onto the corresponding
regions of a HLA-A2 TCR complex (1AO7) (Garboczi et al., 1996).
To compensate for steric clashes between both CD1a and TCR
model, the TCR coordinates were manually tilted 16° along the ver-
tical axis, as determined with the program LSQKAB (Kabsch, 1976)
as part of the CCP4 suite (CCP4, 1994). The final orientation
showed a maximal interaction between the CDRs of the TCR and
the T cell recognition surface and the lipopeptide ligand of CD1a.
Lipopeptide Synthesis, Purification, and T Cell Assay
The lipopeptide compound JH-02215 was obtained as an interme-
diate during the synthesis of Mycobactin S (Hu and Miller, 1997).
The compound was diluted to a 50 µM solution in 1:1 methanol:
water and analyzed by CID-MS/MS to confirm its structure. M. tu-
berculosis strain H37Ra was purchased from Difco (Detroit, MI).
Total lipids were purified by extracting the lyophilized bacteria withCHCl3:MeOH 1:2 and then CHCl3:MeOH 2:1. The extractable lipids
were separated by centrifugation. The total lipids were dried and
mixed vigorously in cold acetone and left on ice for 1 hr, followed
by centrifugation. The acetone soluble fraction contained the en-
riched DDMs. To purify individual molecular species of mycobactin,
including DDM-838 and DDM-642, total M. tuberculosis lipids were
dissolved in 50 mL of 100:25 hexane:chloroform and loaded onto
a solid phase extraction silica gel column (10 × g silica, Alltech,
Waukegan, IL) followed by elution with 40 mL aliquots of hexane:
chloroform:2-propanol:acetic acid in the following ratios: 100:25:5:0,
100:25:10:0, 100:25:15:0 (three times), and 100:25:15:1 (two times).
DDM-838 and related compounds eluted in the 100:25:15:1 eluent
fraction. The lipids in the DDM-containing fraction were then sepa-
rated further by using reversed phase high-performance liquid
chromatography (RP-HPLC) on a C18 column and eluted with a
binary gradient (0 min 20% B, 4 min 20% B, 35 min 60% B, 45 min
60% B, and 50 min 20% B) from 20% to 60% B at 0.7 ml/min (A =
50:30:20:0.02 methanol:acetonitrile:water:trifluoroacetic acid, B =
93:7:0.02 2-propanol:hexane:trifluoroacetic acid). The LC-MS sys-
tem used was a Thermo Finnigan LCQ Advantage quadrupole ion
trap mass spectrometer with a split interface to facilitate fraction
collection. The [M + H]+ of DDM-642, m/z 642, was subjected to
CID-MS/MS analysis, which yielded collision products correspond-
ing to a form of DDM in which the β-hydroxybuturate-lysine moiety
was absent. DDM-856 was generated by hydrolysis of DDM-838 in
acetonitrile:water (80:20) with 0.1% TFA for 24 hr, yielding a product
with [M + Na]+ m/z 878, and the expected collisionally induced
product ions were observed at m/z 740 (loss of salicylic acid ac-
companied by hydrogen transfer) and m/z 682 (cleavage of the
central ester moiety), which indicated that the oxazoline ring had
been hydrolyzed.
Monocyte-derived DCs were prepared from peripheral blood by
centrifugation over Ficoll-Hypaque (Amersham, Piscataway, NJ),
adherence to plastic tissue-culture flask (Falcon, Franklin Lakes,
NJ), culture of adherent cells with 300 U/ml of GM-CSF and 200 U/
ml IL-4 for 72–96 hr, followed by γ-irradiation (5000 rad) as de-
scribed. IL-2 release from J.RT-3, transfected with the αβ chains of
CD8-2 T cells (105/well with 10 ng/ml of PMA) was measured by
culturing T cells and 5 × 104 DCs plus antigen in 200 l/well in 96-
well plates. After 24 hr, 50 l of supernatant was transfered to wells
containing 125 l of media and 104 IL-2-dependent HT-2 cells. Cells
were cultured for 24 hr before adding 1 Ci [3H] thymidine for an
additional 6–24 hr of culture, followed by harvesting and counting
β emissions.
Structure Presentation
The program PyMOL was used to prepare Figures 2, 3, and 4 (De-
Lano, 2002). The programs Molscript (Kraulis, 1991), GRASP (Nicholls
et al., 1991), and Raster3D (Merritt and Bacon, 1997) were used to
prepare Figures 5 and 6.
Supplemental Data
Supplemental Data including five supplemental figures are avail-
able online with this article online at http://www.immunity.com/cgi/
content/full/22/2/209/DC1/.
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